216 filings
Page 4 of 11
8-K
wzv 1ifds210
13 Aug 19
Nephros Announces Listing on Nasdaq Capital Market
7:45am
8-K
1oa19ssqcil
7 Aug 19
Nephros Reports Second Quarter Financial Results
4:15pm
8-K
ufv2qdw2
2 Aug 19
Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July
5:01pm
8-K
0hysrjl
9 Jul 19
Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split
4:10pm
8-K
w6ri779 yvebx9mr3ut0
22 May 19
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
cujfn4d
16 May 19
Nephros Announces $2 Million Private Placement
7:35am
8-K
3dy mamym
8 May 19
Nephros Reports First Quarter Financial Results
4:15pm
8-K
ghx2t8ywjrzn
2 May 19
Nephros Appoints Tom Gwydir to its Board of Directors
10:25am
8-K
rpamk
9 Apr 19
Nephros Announces Preliminary Financial Results for First Quarter 2019
4:15pm
8-K
5g27 xvu0828bgw
12 Mar 19
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
7:50am
8-K
q8vn5swo9qmjrhcr
13 Feb 19
Nephros Appoints Alisa Lask to its Board of Directors
12:00am
8-K
cq6qo
9 Jan 19
Nephros Announces Preliminary Financial Results for Fiscal Year 2018
5:20pm
8-K
zzhq5xc cp
3 Jan 19
Nephros Announces Acquisition of Biocon
9:41am
8-K
gpt933su 19mo7n4
19 Dec 18
Departure of Directors or Certain Officers
4:15pm
8-K
zolo9
10 Dec 18
Other Events
5:23pm
8-K
ag0kjlqvg 5deic
2 Oct 18
Results of Operations and Financial Condition
4:05pm
8-K
7kfj45i
11 Sep 18
Specialty Renal Products Announces $3 Million Series A Financing
12:00am
8-K
mjmdte
13 Aug 18
Nephros Appoints Oliver Spandow to its Board of Directors
4:31pm
8-K
gaag86 sb
12 Jul 18
Nephros Announces Preliminary Financial Results for Second Quarter 2018
9:59am
8-K
plz68vk
24 May 18
Departure of Directors or Certain Officers
4:15pm